letrozole,palbociclib
pfizer,novartis
['mbc', 'paloma 2']
 updated os data of cdk4/6i in 1 and 2 line for hr+/her2- mbc pts. after presentation of os data from the paloma 2 trial. the by is still ongoing: "are all cyclin-dependent kinases 4/6 inhibitors created equal?" #asco22 
Medical Oncologist at Grupo Oncoclínicas. Focused on Breast Cancer and Cancer Genetic ??. Tweets are my own.